Moderna and Invio biotechnology companies have been awarded contracts by different United states government agencies to develop a vaccine against the novel coronavirus (2019-nCoV) in Whuhan China.

China Quarantines 11 Million Residents Due To Coronavirus Outbreak


The United States recognizing the seriousness of the coronvirus outbreak has awarded contracts for the development of a vaccine. The quickest vaccine development platforms are the Mrna system of Moderna and the DNA vaccine system of Invio

The CDC describes both the nature of coronavirus and the outbreak in China as follows:

“Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases, says the CDC. Coronaviruses that infect animals can also evolve and become a human coronavirus. The best-known human coronaviruses are Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Outbreaks of a Novel Coronavirus (nCoV), now known as 2019-nCoV, are causing pneumonia-related infections in various counties in 2020

As of January 26, 2020, there are no approved antiviral medications to treat or vaccines to prevent the 2019-nCoV virus in the USA, says the Centers for Disease Control and Prevention (CDC).

2019-nCoV Outbreak

The WHO China Country Office was informed of cases of pneumonia of unknown etiology (cause) detected in Wuhan City, Hubei Province of China on December 31, 2019. A novel coronavirus (2019-nCoV) was identified as the causative virus by Chinese authorities”

The WHO has declared a country wide emergency in China and is monitoring the situation regarding the need for a pandemic world wide emergency should the virus spread within other countries.